XML 45 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes
12 Months Ended
Dec. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes:

The components of income tax expense are as follows:

 

 

Year Ended

 

 

 

December 28,
2024

 

 

December 30,
2023

 

 

December 31,
2022

 

 

 

(in thousands)

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

40,688

 

 

$

28,326

 

 

$

47,963

 

State

 

 

1,156

 

 

 

879

 

 

 

987

 

Foreign

 

 

3,409

 

 

 

4,647

 

 

 

2,901

 

 

 

 

45,253

 

 

 

33,852

 

 

 

51,851

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

(25,287

)

 

 

(22,429

)

 

 

(31,622

)

State

 

 

(871

)

 

 

242

 

 

 

(1,506

)

Foreign

 

 

(318

)

 

 

(242

)

 

 

(473

)

 

 

 

(26,476

)

 

 

(22,429

)

 

 

(33,601

)

Total income tax expense

 

$

18,777

 

 

$

11,423

 

 

$

18,250

 

 

The income before tax is comprised of the following:

 

 

Year Ended

 

 

 

December 28,
2024

 

 

December 30,
2023

 

 

December 31,
2022

 

 

 

(in thousands)

 

Domestic operations

 

$

207,747

 

 

$

107,640

 

 

$

239,527

 

Foreign operations

 

$

12,700

 

 

$

24,942

 

 

$

2,057

 

The provision for income taxes differs from the amount of income tax determined by applying the applicable U.S. federal income tax rate of 21% for the years ended December 28, 2024, December 30, 2023 and December 31, 2022, to income before provision for income taxes as follows:

 

 

Year Ended

 

 

 

December 28,
2024

 

 

December 30,
2023

 

 

December 31,
2022

 

 

 

(in thousands, except for percentages)

 

Federal income tax provision at statutory rate

 

$

46,294

 

 

$

27,842

 

 

$

50,732

 

State taxes, net of federal effect

 

 

2,171

 

 

 

1,389

 

 

 

467

 

Foreign taxes, net of federal effect

 

 

854

 

 

 

(2,000

)

 

 

(481

)

Foreign Derived Intangible Income (FDII) Deduction

 

 

(16,960

)

 

 

(12,662

)

 

 

(25,445

)

US tax on foreign source income

 

 

(207

)

 

 

184

 

 

 

1,423

 

Tax effect of share-based compensation

 

 

(6,883

)

 

 

(2,288

)

 

 

(2,497

)

Non-deductible officer's compensation

 

 

3,412

 

 

 

2,301

 

 

 

1,910

 

Research and development tax credit

 

 

(6,640

)

 

 

(6,410

)

 

 

(7,146

)

Change in tax reserves

 

 

(2,648

)

 

 

(1,133

)

 

 

(1,084

)

Change in valuation allowance

 

 

(1,790

)

 

 

2,180

 

 

 

(276

)

Withholding taxes

 

 

785

 

 

 

640

 

 

 

937

 

Other

 

 

389

 

 

 

1,380

 

 

 

(290

)

Provision for income taxes

 

$

18,777

 

 

$

11,423

 

 

$

18,250

 

Effective tax rate

 

 

9

 %

 

 

9

 %

 

 

8

 %

Prior year amounts were reclassified to conform to current year classification requirements for comparability purposes. The total tax provision amounts remained unchanged.

Deferred tax assets and liabilities are comprised of the following:

 

 

 

 

 

 

 

 

 

December 28,
2024

 

 

December 30,
2023

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

Reserves and accruals

 

$

20,315

 

 

$

16,658

 

Deferred revenue

 

 

4,677

 

 

 

4,082

 

Share-based compensation

 

 

3,792

 

 

 

3,495

 

Tax credit carryforward

 

 

12,170

 

 

 

13,960

 

Net operating losses

 

 

1,618

 

 

 

1,088

 

Depreciation and amortization

 

 

162

 

 

 

156

 

Capitalized research and development

 

 

48,943

 

 

 

34,165

 

Operating lease liabilities

 

 

2,968

 

 

 

3,744

 

Other

 

 

1,162

 

 

 

2,875

 

Gross deferred tax assets

 

 

95,807

 

 

 

80,223

 

Less: valuation allowance

 

 

(12,170

)

 

 

(13,960

)

Total deferred tax assets after valuation allowance

 

 

83,637

 

 

 

66,263

 

Deferred tax liabilities:

 

 

 

 

 

 

Depreciation and amortization

 

 

(38,144

)

 

 

(43,908

)

Operating lease right of use assets

 

 

(2,682

)

 

 

(3,519

)

Other

 

 

(4

)

 

 

 

Gross deferred tax liabilities

 

 

(40,830

)

 

 

(47,427

)

Net deferred tax assets

 

$

42,807

 

 

$

18,836

 

At December 28, 2024 and December 30, 2023, the Company had recorded valuation allowances of $12.2 million and $14.0 million, respectively, on a certain portion of the Company’s deferred tax assets to reflect the deferred tax assets at the net amount that is more likely than not to be realized. The Company maintains a valuation allowance against its federal foreign tax credit carryforwards of $0.3 million and state research and development credits of $11.9 million.

In assessing the realizability of deferred tax assets, the Company uses a more likely than not standard. If it is determined that it is more-likely-than-not that deferred tax assets will not be realized, a valuation allowance must be established against the deferred tax assets. The ultimate realization of the assets is dependent on the generation of future taxable income during the periods in which the associated temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income and tax planning strategies when making this assessment. In making the determination that it is more likely than not that the Company’s deferred tax assets will be realized as of December 28, 2024, the Company relied primarily on the reversal of deferred tax liabilities as well as projected future taxable income.

At December 28, 2024, the Company had tax effected federal, state, and foreign net operating loss carryforwards of $0.5 million, $0.9 million and $0.2 million, respectively. The federal, state and foreign net operating loss carryforwards expire on various dates beginning in 2033 through 2049.

At December 28, 2024, the Company had foreign tax credit carryforwards and state research & development credits of $0.3 million, and $16.8 million, respectively. The foreign tax credit carryforwards are set to expire at various dates beginning December 31, 2032. The state research & development credit carryforwards are set to expire at various dates beginning December 31, 2028.

As of December 28, 2024, the Company has not provided U.S. income taxes on all its foreign earnings. The Company continues to permanently reinvest the cash held offshore to support its working capital needs. The Company has accrued $0.5 million for additional foreign withholding taxes from an expected liquidating distribution from its Israel entity.

The total amount of unrecognized tax benefits are as follows:

 

 

Year Ended

 

 

 

December 28,
2024

 

 

December 30,
2023

 

 

December 31,
2022

 

 

 

(in thousands)

 

Balance, beginning of the period

 

$

13,142

 

 

$

13,010

 

 

$

12,373

 

Gross increases—tax positions in prior period

 

 

1,416

 

 

 

29

 

 

 

456

 

Gross decreases—tax positions in prior period

 

 

(33

)

 

 

(100

)

 

 

 

Gross increases—current-period tax positions

 

 

1,761

 

 

 

1,785

 

 

 

1,729

 

Closure of audit/statute limitation

 

 

(3,291

)

 

 

(1,582

)

 

 

(1,548

)

Balance, end of the period

 

$

12,995

 

 

$

13,142

 

 

$

13,010

 

The unrecognized tax benefits at December 28, 2024 and December 30, 2023 were $13.0 million and $13.1 million, respectively, of which $6.7 million and $7.2 million, respectively, would be reflected as an adjustment to income tax expense if recognized. The year over year decrease from 2023 to 2024 is primarily due to expiring tax statutes, offset by additional unrecognized tax benefits related to foreign net operating losses. It is reasonably possible that certain amounts of unrecognized tax benefits may reverse in the next 12 months; however, the Company does not expect such reversals to have a significant impact on its results of operations or financial position.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the years ended December 28, 2024, December 30, 2023 and December 31, 2022, the Company recognized approximately $(223) thousand, $146 thousand and $149 thousand, respectively, in interest and penalties (benefit) expense associated with uncertain tax positions. As of December 28, 2024 and December 30, 2023, the Company had accrued interest and penalties expense included in the table of unrecognized tax benefits of $564 thousand and $823 thousand, respectively.

The Company is subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. The Company is subject to ordinary statute of limitation rules of three and four years for federal and state returns, respectively. However, due to tax attribute carryforwards, the Company is subject to examination for tax years 2015 forward for U.S. federal tax purposes with respect to carryforward amounts. The Company is also subject to examination in various states for tax years 2003 forward with respect to carryforward amounts. The Company is subject to examination for tax years 2016 forward for various foreign jurisdictions. The Company believes that adequate amounts have been reserved for any adjustments that may ultimately result from any future examinations of these years.

In the normal course of business, the Company is subject to tax audits in various jurisdictions, and such jurisdictions may assess additional income taxes or other taxes against it. Although the Company believes its tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different from the Company’s historical income tax provisions and accruals. The results of an audit or litigation could have a material adverse effect on the Company’s results of operations or cash flows in the period or periods for which that determination is made.